Ackman goes after Allergan CEO Pyott in Valeant/Pershing takeover bid

Hedge fund mogul Bill Ackman says Allergan chairman & CEO David Pyott has a 'disabling' conflict of interest stemming from a takeover bid by Ackman's Pershing Capital hedge fund and Valeant Pharmaceuticals.

Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.

News Well, Cosmetic/Aesthetic, Mergers & Acquisitions

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mOG1QH